|
| |
XAGE1D
Gene Information from Publications |
| Publication Link |
Summary of findings |
| 15800911 |
XAGE-1 expression in normal and cancerous tissues is regulated by methylation of the CpG island in the gene promoter |
| 12479262 |
transcription of the XAGE-1 gene is initiated from two distinct start sites, resulting in two overlapping transcripts, XAGE-1a and XAGE-1b; XAGE-1 is expressed in a diverse range of cancers |
| 17335148 |
XAGE-1b is a promising target molecule for a cancer vaccine against lung cancer. |
| 11992404 |
The XAGE family of cancer/testis-associated genes: alignment and expression profile in normal tissues, melanoma lesions and Ewing's sarcoma |
| 16061866 |
XAGE-1b is highly and strongly expressed in lung adenocarcinoma and immunogenic in patients |
XAGE1D results (if any) from reagent suppliers |
|
XAGE-1 (T-13) Antibody sc-50196
Species, Gene Name, Gene ID, Chromosome Location, Isoform (mRNA) Accession #, Protein Accession #, OMIM™ Number. Human, XAGE1D, 9503, Xp11.22, NM_020411, ...
http://www.scbt.com/datasheet-50196-xage-1-t-13-antibody.htm...
|
 |
XAGE Antibody / XAGE Antibodies
PRODUCT NAME, CATALOG #, ISOTYPE, EPITOPE, APPLICATIONS, SPECIES. XAGE-1 (L-16) Antibody, sc-50194, goat IgG, Internal (h), WB, IF, ELISA, human ...
http://www.scbt.com/table-xage.html...
|
 |
XAGE-1 (Y-19) Antibody sc-50197
... Numéro d'accès d´isoforme d´ARNm, Numéro d'accès de la protéine, Numéro OMIM ™. Humain, XAGE1D, 9503, Xp11.22, NM_020411, NM_133430, NM_133431 · Q9HD64 ...
http://www.scbt.com/fr/datasheet-50197-xage-1-y-19-antibody....
|
 |
XAGE-1 (Y-19) Antibody sc-50197
... isoformas de RNA mensageiro, Numero de acesso de proteina, OMIM&trande; Numero. Humano, XAGE1D, 9503, Xp11.22, NM_020411, NM_133430, NM_133431 · Q9HD64 ...
http://www.scbt.com/pt/datasheet-50197-xage-1-y-19-antibody....
|
 |
Search Bioportfolio and other Life Science Sites for XAGE1D,
or search for XAGE1D on BioPortfolio's antibody search engine. This page has been viewed 93 times Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|